drugset / Trial / NCT01255046
Study of STA-1 as an Add-on Treatment to Donepezil
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of STA-1 vs placebo as an add-on treatment to donepezil in patients with mild to moderate Alzheimer's Disease (AD).
Timeline
- Start
- 2015-12
- Primary completion
- 2018-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | STA-1 | Unknown | 600 mg | — |
| Comparator | Donepezil | Small molecule | 10 mg | — |